Stellar Biotechnologies revenues up but losses grow
Stellar Biotechnologies’ revenues increased slightly during the third quarter of 2016 but losses widened as the company signed a new partnership with a French company and held an offering for institutional investors, the company said in a quarterly earnings report Aug. 8. Stellar revenues increased slightly from $157,748 during the third quarter of 2015 to Read More →
Report recommends conditions for proposed Oxnard peaker plant
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Tax measures could alter tri-county marijuana market
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Stellar Biotechnologies offerings raise $6.75 million
Stellar Biotechnologies, a Port Hueneme-based company which makes medicines from the blood of animals found only off the coast of California, closed two private offerings July 6. Stellar closed one offering of 1.7 million common shares sold to institutional investors for $4 per share. In a separate concurrent offering, the company also sold 1.3 million Read More →
Tri-county stocks fall after Britain votes to exit EU
Stock prices for many companies headquartered in the Tri-Counties fell June 24 as investors reacted to Britain’s vote to leave the European Union. Thousand Oaks-based biotech giant Amgen dropped $5.82 or 3.82 percent. Two other companies based in Thousand Oaks, Teledyne and Inphi, saw stock prices decline $5.72 or 5.66 percent and $3.44 or 10.52 Read More →
Preparing today’s military leaders for tomorrow
By Mary Anne Rooney A diverse group of 150 guests gathered at the National Security Forum of the Air War College this past week at Maxwell Air Force Base in Montgomery, Ala. I was nominated by an alumni of the NSF through my membership in the Oxnard Ambassadors and was honored to be selected Read More →
Stellar Biotechnologies forming Paris-based company in joint venture
Stellar Biotechnologies will form a Paris-based company in a joint venture with Neovacs. The companies announced the partnership May 11. Neovacs, which is based in Paris, will own 70 percent of the new company, called Neostell. Stellar Biotechnologies will own 30 percent. Based in Port Hueneme, Stellar Biotechnologies makes a protein for immunotherapy treatments using Read More →
